Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Kranaster

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 18, 2017
Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depressionLaura Kranaster, Carolin Hoyer, Suna S Aksay, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 3, 2014
Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuseDaniela Muhl, Markus Kathmann, Carolin Hoyer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 22, 2016
Electroconvulsive therapy increases temporal gray matter volume and cortical thicknessAlexander Sartorius, Traute Demirakca, Andreas Böhringer, et al.
Journal of Affective Disorders|October 2, 2015
Serum lipid profile changes after successful treatment with electroconvulsive therapy in major depression: A prospective pilot trialSuna Su Aksay, Jan Malte Bumb, Christoph Janke, et al.
Translational Psychiatry|June 6, 2021
Methylome-wide change associated with response to electroconvulsive therapy in depressed patientsLea Sirignano, Josef Frank, Laura Kranaster, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 25, 2017
Electroconvulsive therapy enhances the anti-ageing hormone Klotho in the cerebrospinal fluid of geriatric patients with major depressionCarolin Hoyer, Alexander Sartorius, Suna Su Aksay, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 24, 2020
Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure qualityAlexander Sartorius, Juliane Beuschlein, Dmitry Remennik, et al.
Schizophrenia Research|September 11, 2013
Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophreniaLimin Sun, Nazareth Castellanos, Christine Grützner, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 26, 2017
Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective studyLaura Kranaster, Carolin Hoyer, Suna Su Aksay, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 24, 2009
Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophreniaDagmar Koethe, Laura Kranaster, Carolin Hoyer, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|July 18, 2017
Antidepressant efficacy of electroconvulsive therapy is associated with a reduction of the innate cellular immune activity in the cerebrospinal fluid in patients with depressionLaura Kranaster, Carolin Hoyer, Suna S Aksay, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 3, 2014
Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuseDaniela Muhl, Markus Kathmann, Carolin Hoyer, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 22, 2016
Electroconvulsive therapy increases temporal gray matter volume and cortical thicknessAlexander Sartorius, Traute Demirakca, Andreas Böhringer, et al.
Journal of Affective Disorders|October 2, 2015
Serum lipid profile changes after successful treatment with electroconvulsive therapy in major depression: A prospective pilot trialSuna Su Aksay, Jan Malte Bumb, Christoph Janke, et al.
Translational Psychiatry|June 6, 2021
Methylome-wide change associated with response to electroconvulsive therapy in depressed patientsLea Sirignano, Josef Frank, Laura Kranaster, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 25, 2017
Electroconvulsive therapy enhances the anti-ageing hormone Klotho in the cerebrospinal fluid of geriatric patients with major depressionCarolin Hoyer, Alexander Sartorius, Suna Su Aksay, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 24, 2020
Empirical ratio of the combined use of S-ketamine and propofol in electroconvulsive therapy and its impact on seizure qualityAlexander Sartorius, Juliane Beuschlein, Dmitry Remennik, et al.
Schizophrenia Research|September 11, 2013
Evidence for dysregulated high-frequency oscillations during sensory processing in medication-naïve, first episode schizophreniaLimin Sun, Nazareth Castellanos, Christine Grützner, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 26, 2017
Electroconvulsive therapy enhances endocannabinoids in the cerebrospinal fluid of patients with major depression: a preliminary prospective studyLaura Kranaster, Carolin Hoyer, Suna Su Aksay, et al.
European Archives of Psychiatry and Clinical Neuroscience|January 24, 2009
Binocular depth inversion as a paradigm of reduced visual information processing in prodromal state, antipsychotic-naïve and treated schizophreniaDagmar Koethe, Laura Kranaster, Carolin Hoyer, et al.
Pageof 6